258 related articles for article (PubMed ID: 20951749)
1. Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism.
Gao F; Zhang Z; Bu H; Huang Y; Gao Z; Shen J; Zhao C; Li Y
J Control Release; 2011 Jan; 149(2):168-74. PubMed ID: 20951749
[TBL] [Abstract][Full Text] [Related]
2. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats.
Zhang Z; Gao F; Bu H; Xiao J; Li Y
Nanomedicine; 2012 Jul; 8(5):740-7. PubMed ID: 21930110
[TBL] [Abstract][Full Text] [Related]
4. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
5. Bile salts enhance the intestinal absorption of lipophilic drug loaded lipid nanocarriers: mechanism and effect in rats.
Zhang Z; Gao F; Jiang S; Chen L; Liu Z; Yu H; Li Y
Int J Pharm; 2013 Aug; 452(1-2):374-81. PubMed ID: 23694804
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic properties and bioequivalence of candesartan cilexetil in Korean healthy volunteers.
Jeon JY; Im YJ; Kim Y; Han SM; Jo MJ; Shin DH; Yoo JS; Moon BK; Kim BK; Lee BH; Choi YH; Cho BS; Jang HY; Chae SW; Kim MG
Drug Dev Ind Pharm; 2013 Sep; 39(9):1296-9. PubMed ID: 23030309
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of solid oral dosage form incorporating candesartan nanoparticles.
Nekkanti V; Pillai R; Venkateshwarlu V; Harisudhan T
Pharm Dev Technol; 2009; 14(3):290-8. PubMed ID: 19235553
[TBL] [Abstract][Full Text] [Related]
8. Formulation and Optimization of Candesartan Cilexetil Nano Lipid Carrier: In Vitro and In Vivo Evaluation.
Paudel A; Ameeduzzafar ; Imam SS; Fazil M; Khan S; Hafeez A; Ahmad FJ; Ali A
Curr Drug Deliv; 2017; 14(7):1005-1015. PubMed ID: 28034361
[TBL] [Abstract][Full Text] [Related]
9. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats.
Gorain B; Choudhury H; Kundu A; Sarkar L; Karmakar S; Jaisankar P; Pal TK
Colloids Surf B Biointerfaces; 2014 Mar; 115():286-94. PubMed ID: 24388859
[TBL] [Abstract][Full Text] [Related]
10. A high-drug-loading self-assembled nanoemulsion enhances the oral absorption of probucol in rats.
Zhang Z; Huang J; Jiang S; Liu Z; Gu W; Yu H; Li Y
J Pharm Sci; 2013 Apr; 102(4):1301-6. PubMed ID: 23378294
[TBL] [Abstract][Full Text] [Related]
11. Corroboration of naringin effects on the intestinal absorption and pharmacokinetic behavior of candesartan cilexetil solid dispersions using in-situ rat models.
Surampalli G; K Nanjwade B; Patil PA
Drug Dev Ind Pharm; 2015; 41(7):1057-65. PubMed ID: 24918161
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of candesartan.
Gleiter CH; Mörike KE
Clin Pharmacokinet; 2002; 41(1):7-17. PubMed ID: 11825094
[TBL] [Abstract][Full Text] [Related]
13. Three dimensional macroporous hydroxyapatite/chitosan foam-supported polymer micelles for enhanced oral delivery of poorly soluble drugs.
Zhang Y; Dong K; Wang F; Wang H; Wang J; Jiang Z; Diao S
Colloids Surf B Biointerfaces; 2018 Oct; 170():497-504. PubMed ID: 29960950
[TBL] [Abstract][Full Text] [Related]
14. A self-assembled nanocarrier loading teniposide improves the oral delivery and drug concentration in tumor.
Zhang Z; Ma L; Jiang S; Liu Z; Huang J; Chen L; Yu H; Li Y
J Control Release; 2013 Feb; 166(1):30-7. PubMed ID: 23266449
[TBL] [Abstract][Full Text] [Related]
15. Determination of candesartan cilexetil, candesartan and a metabolite in human plasma and urine by liquid chromatography and fluorometric detection.
Stenhoff H; Lagerström PO; Andersen C
J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(2):411-7. PubMed ID: 10510797
[TBL] [Abstract][Full Text] [Related]
16. Candesartan cilexetil loaded nanodelivery systems for improved oral bioavailability.
Dudhipala N; Veerabrahma K
Ther Deliv; 2017 Feb; 8(2):79-88. PubMed ID: 28088883
[TBL] [Abstract][Full Text] [Related]
17. In situ niosome forming maltodextrin proniosomes of candesartan cilexetil: In vitro and in vivo evaluations.
Yuksel N; Bayindir ZS; Aksakal E; Ozcelikay AT
Int J Biol Macromol; 2016 Jan; 82():453-63. PubMed ID: 26455402
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of candesartan after single and repeated doses of candesartan cilexetil in young and elderly healthy volunteers.
Hübner R; Högemann AM; Sunzel M; Riddell JG
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S19-25. PubMed ID: 9331000
[TBL] [Abstract][Full Text] [Related]
19. Development and in vitro/in vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil.
AboulFotouh K; Allam AA; El-Badry M; El-Sayed AM
Eur J Pharm Sci; 2017 Nov; 109():503-513. PubMed ID: 28889028
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of gender difference in pharmacokinetics of Candesartan cilexetil in the fasted state by RP-HPLC: A single dose comparative study.
Nawaz HA; Masood MI; Abbas M; Usman M; Khan AM; Rasheed H; Riffat S
Pak J Pharm Sci; 2019 May; 32(3):1019-1024. PubMed ID: 31278715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
